{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:58:59Z","timestamp":1788382739039,"version":"build-2803163510"},"reference-count":41,"publisher":"American Diabetes Association","issue":"2","license":[{"start":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T00:00:00Z","timestamp":1548028800000},"content-version":"vor","delay-in-days":46,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/100008871","name":"JDRF","doi-asserted-by":"publisher","award":["17-2013-312"],"award-info":[{"award-number":["17-2013-312"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>The importance of renin-angiotensin-aldosterone system (RAAS) activation in retinopathy for long-standing diabetes is not well understood. We determined retinopathy stage and evaluated associations with other vascular complications before and after physiological RAAS activation in adults with long-standing (\u226550 years duration) type 1 diabetes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>Participants underwent retinal examination by digital funduscopic photography and optical coherence tomography and were classified as having nonproliferative diabetic retinopathy (NPDR), proliferative diabetic retinopathy (PDR), or no diabetic retinopathy (NDR) with or without diabetic macular edema (DME). Neuropathy was measured by clinical neuropathy examination scores, electrophysiologically, and by corneal confocal microscopy. Renal function was measured by inulin and para-aminohippurate clearance methods. Arterial stiffness was measured by applanation tonometry. Renal function, blood pressure, and arterial stiffness were measured before and after RAAS activation with angiotensin II (ANGII). Associations were determined using linear regression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Twelve (16%) of the 75 participants had NDR, 24 (32%) had NPDR, and 39 (52%) had PDR. A low overall prevalence of DME (4%) was observed. Those with PDR had worse nerve function and reduced corneal nerve density, were more likely to have macrovascular disease, and had increased arterial stiffness in response to ANGII compared with those with NPDR or NDR. Prevalence of kidney disease or renal hemodynamic function did not differ by retinopathy status.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>PDR was associated with neuropathy severity and cardiovascular and peripheral vascular disease. In those with PDR, RAAS activation may be linked to vascular stiffening, an effect that persists in long-standing type 1 diabetes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc18-1809","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T22:17:43Z","timestamp":1544134663000},"page":"273-280","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":29,"title":["Retinopathy and RAAS Activation: Results From the Canadian Study of Longevity in Type 1 Diabetes"],"prefix":"10.2337","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9171-8952","authenticated-orcid":false,"given":"Julie A.","family":"Lovshin","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Sunnybrook Health Sciences Centre, Department of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya","family":"Lytvyn","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif E.","family":"Lovblom","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Katz","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Boulet","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5160-2947","authenticated-orcid":false,"given":"Petter","family":"Bjornstad","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, and Division of Nephrology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesta","family":"Lai","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Cham","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Tse","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Orszag","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4172-5537","authenticated-orcid":false,"given":"Hillary A.","family":"Keenan","sequence":"additional","affiliation":[{"name":"Research Division, Joslin Diabetes Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narinder","family":"Paul","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5805-4883","authenticated-orcid":false,"given":"Vera","family":"Bril","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylen D.","family":"McReelis","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Brent","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5885-0046","authenticated-orcid":false,"given":"Bruce A.","family":"Perkins","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada"},{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4164-0429","authenticated-orcid":false,"given":"David Z.I.","family":"Cherney","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Physiology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2018,12,6]]},"reference":[{"key":"2022031221340087900_B1","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.2337\/diacare.26.2007.S99","article-title":"Diabetic retinopathy","volume":"26","author":"Fong","year":"2003","journal-title":"Diabetes Care"},{"key":"2022031221340087900_B2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"2022031221340087900_B3","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1016\/S2214-109X(13)70113-X","article-title":"Causes of vision loss worldwide, 1990-2010: a systematic analysis","volume":"1","author":"Bourne","year":"2013","journal-title":"Lancet Glob Health"},{"key":"2022031221340087900_B4","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra1005073","article-title":"Diabetic retinopathy","volume":"366","author":"Antonetti","year":"2012","journal-title":"N Engl J Med"},{"key":"2022031221340087900_B5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2337\/diacare.28.1.164","article-title":"Diabetic nephropathy: diagnosis, prevention, and treatment","volume":"28","author":"Gross","year":"2005","journal-title":"Diabetes Care"},{"key":"2022031221340087900_B6","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ecl.2013.06.001","article-title":"Diabetic neuropathy","volume":"42","author":"Vinik","year":"2013","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2022031221340087900_B7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.diabres.2004.09.008","article-title":"Arterial stiffness is associated with diabetic retinopathy in type 2 diabetes","volume":"68","author":"Ogawa","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031221340087900_B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-008055232-3.64014-0","article-title":"Diabetic retinopathy","volume-title":"xPharm: The Comprehensive Pharmacology Reference","author":"Margalit","year":"2008"},{"key":"2022031221340087900_B9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00508-017-1270-3","article-title":"Blood pressure profile is associated with microalbuminuria and retinopathy in hypertensive nondiabetic patients","volume":"130","author":"Karadag","year":"2018","journal-title":"Wien Klin Wochenschr"},{"key":"2022031221340087900_B10","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.atherosclerosis.2014.12.023","article-title":"Arterial stiffness in diabetes mellitus","volume":"238","author":"Prenner","year":"2015","journal-title":"Atherosclerosis"},{"key":"2022031221340087900_B11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/jhh.2011.37","article-title":"How does hypertension affect your eyes","volume":"26","author":"Bhargava","year":"2012","journal-title":"J Hum Hypertens"},{"key":"2022031221340087900_B12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa0808400","article-title":"Renal and retinal effects of enalapril and losartan in type 1 diabetes","volume":"361","author":"Mauer","year":"2009","journal-title":"N Engl J Med"},{"key":"2022031221340087900_B13","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96968","article-title":"Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes","volume":"3","author":"Lovshin","year":"2018","journal-title":"JCI Insight"},{"key":"2022031221340087900_B14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12933-015-0318-9","article-title":"Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort","volume":"15","author":"Bai","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"2022031221340087900_B15","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.2337\/dc16-0102","article-title":"Commonly measured clinical variables are not associated with burden of complications in long-standing type 1 diabetes: results from the Canadian Study of Longevity in Diabetes","volume":"39","author":"Weisman","year":"2016","journal-title":"Diabetes Care"},{"key":"2022031221340087900_B16","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1681\/ASN.2005080872","article-title":"Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes","volume":"17","author":"Sochett","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2022031221340087900_B17","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"2022031221340087900_B18","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1681\/ASN.2004110905","article-title":"Endothelial nitric oxide synthase gene\/gender interactions and the renal hemodynamic response to angiotensin II","volume":"16","author":"Page","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2022031221340087900_B19","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/j.1523-1755.2005.00588.x","article-title":"Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes","volume":"68","author":"Cherney","year":"2005","journal-title":"Kidney Int"},{"key":"2022031221340087900_B20","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1681\/ASN.V132446","article-title":"Variation in the renin angiotensin system throughout the normal menstrual cycle","volume":"13","author":"Chidambaram","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"2022031221340087900_B21","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1172\/JCI102534","article-title":"Evaluation of renal resistances, with special reference to changes in essential hypertension","volume":"30","author":"Gomez","year":"1951","journal-title":"J Clin Invest"},{"key":"2022031221340087900_B22","doi-asserted-by":"crossref","first-page":"F967","DOI":"10.1152\/ajprenal.00415.2016","article-title":"The Gomez\u2019 equations and renal hemodynamic function in kidney disease research","volume":"311","author":"Bjornstad","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022031221340087900_B23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2337\/dc09-1303","article-title":"Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot study","volume":"33","author":"Cherney","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031221340087900_B24","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1464-5491.2012.03644.x","article-title":"Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications","volume":"29","author":"Herman","year":"2012","journal-title":"Diabet Med"},{"key":"2022031221340087900_B25","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2337\/dc17-2475","article-title":"Adiposity impacts intrarenal hemodynamic function in adults with long-standing type 1 diabetes with and without diabetic nephropathy: results from the Canadian Study of Longevity in Type 1 Diabetes","volume":"41","author":"Bjornstad","year":"2018","journal-title":"Diabetes Care"},{"key":"2022031221340087900_B26","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031221340087900_B27","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.2337\/dc06-2222","article-title":"Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-Year Medalist Study","volume":"30","author":"Keenan","year":"2007","journal-title":"Diabetes Care"},{"key":"2022031221340087900_B28","doi-asserted-by":"crossref","first-page":"F412","DOI":"10.1152\/ajprenal.00445.2017","article-title":"Dapagliflozin in focal segmental glomerulosclerosis: a combined human-rodent pilot study","volume":"314","author":"Rajasekeran","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022031221340087900_B29","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2174\/157339908786241151","article-title":"Insights into the regulation of renal hemodynamic function in diabetic mellitus","volume":"4","author":"Cherney","year":"2008","journal-title":"Curr Diabetes Rev"},{"key":"2022031221340087900_B30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2337\/dc10-1219","article-title":"The acute effect of clamped hyperglycemia on the urinary excretion of inflammatory cytokines\/chemokines in uncomplicated type 1 diabetes: a pilot study","volume":"34","author":"Cherney","year":"2011","journal-title":"Diabetes Care"},{"key":"2022031221340087900_B31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1139\/y11-106","article-title":"Systemic hemodynamic function in humans with type 1 diabetes treated with protein kinase C\u03b2 inhibition and renin-angiotensin system blockade: a pilot study","volume":"90","author":"Cherney","year":"2012","journal-title":"Can J Physiol Pharmacol"},{"key":"2022031221340087900_B32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2337\/dc08-1609","article-title":"Effect of protein kinase C\u03b2 inhibition on renal hemodynamic function and urinary biomarkers in humans with type 1 diabetes: a pilot study","volume":"32","author":"Cherney","year":"2009","journal-title":"Diabetes Care"},{"key":"2022031221340087900_B33","doi-asserted-by":"crossref","first-page":"193514","DOI":"10.1155\/2013\/193514","article-title":"Relationship between stage of diabetic retinopathy and pulse wave velocity in Japanese patients with type 2 diabetes","volume":"2013","author":"Tanaka","year":"2013","journal-title":"J Diabetes Res"},{"key":"2022031221340087900_B34","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2337\/dc12-0864","article-title":"Relationship between retinal blood flow and renal function in patients with type 2 diabetes and chronic kidney disease","volume":"36","author":"Nagaoka","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031221340087900_B35","doi-asserted-by":"crossref","first-page":"e0149448","DOI":"10.1371\/journal.pone.0149448","article-title":"Chronic kidney disease and diabetic retinopathy in patients with type 2 diabetes","volume":"11","author":"Rodr\u00edguez-Poncelas","year":"2016","journal-title":"PLoS One"},{"key":"2022031221340087900_B36","doi-asserted-by":"crossref","first-page":"6090749","DOI":"10.1155\/2016\/6090749","article-title":"Diabetic retinopathy is strongly predictive of cardiovascular autonomic neuropathy in type 2 diabetes","volume":"2016","author":"Huang","year":"2016","journal-title":"J Diabetes Res"},{"key":"2022031221340087900_B37","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2337\/dc12-0850","article-title":"Arterial stiffness is associated with cardiovascular, renal, retinal, and autonomic disease in type 1 diabetes","volume":"36","author":"Theilade","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031221340087900_B38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10286-010-0062-x","article-title":"Cardiovascular autonomic neuropathy and other complications in type 1 diabetes","volume":"20","author":"Pavy-Le Traon","year":"2010","journal-title":"Clin Auton Res"},{"key":"2022031221340087900_B39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/MED.0000000000000074","article-title":"Early diabetic nephropathy in type 1 diabetes: new insights","volume":"21","author":"Bjornstad","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2022031221340087900_B40","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/ki.2013.221","article-title":"Long-term hemodynamic and molecular effects persist after discontinued renin-angiotensin system blockade in patients with type 1 diabetes mellitus","volume":"84","author":"Cherney","year":"2013","journal-title":"Kidney Int"},{"key":"2022031221340087900_B41","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2337\/dc17-2250","article-title":"Differential association of microvascular attributions with cardiovascular disease in patients with long duration of type 1 diabetes","volume":"41","author":"Gordin","year":"2018","journal-title":"Diabetes Care"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc18-1809","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/2\/273\/527280\/dc181809.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/2\/273\/527280\/dc181809.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T23:51:04Z","timestamp":1647129064000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/42\/2\/273\/30486\/Retinopathy-and-RAAS-Activation-Results-From-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,6]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,12,6]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc18-1809","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,6]]}}}